Gland Pharma Limited (BOM:543245)

Gland Pharma Statistics

Total Valuation

Gland Pharma has a market cap or net worth of INR 251.51 billion. The enterprise value is 226.58 billion.

Market Cap	251.51B
Enterprise Value	226.58B

Important Dates

The last earnings date was Monday, February 3, 2025.

Earnings Date	Feb 3, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.01%
Shares Change (QoQ)	+0.08%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	73.18M

Valuation Ratios

The trailing PE ratio is 35.71.

PE Ratio	35.71
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	2.99
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	32.17
EV / Sales	3.95
EV / EBITDA	16.37
EV / EBIT	25.03
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.04
Debt / EBITDA	0.24
Debt / FCF	n/a
Interest Coverage	22.58

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	6.37%
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	13.59M
Profits Per Employee	1.67M
Employee Count	4,217
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -22.46% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-22.46%
50-Day Moving Average	1,643.56
200-Day Moving Average	1,789.24
Relative Strength Index (RSI)	47.05
Average Volume (20 Days)	7,684

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Gland Pharma had revenue of INR 57.29 billion and earned 7.04 billion in profits. Earnings per share was 42.76.

Revenue	57.29B
Gross Profit	31.72B
Operating Income	9.05B
Pretax Income	10.73B
Net Income	7.04B
EBITDA	13.65B
EBIT	9.05B
Earnings Per Share (EPS)	42.76

Balance Sheet

The company has 28.20 billion in cash and 3.27 billion in debt, giving a net cash position of 24.93 billion.

Cash & Cash Equivalents	28.20B
Total Debt	3.27B
Net Cash	24.93B
Net Cash Per Share	n/a
Equity (Book Value)	87.88B
Book Value Per Share	533.63
Working Capital	n/a

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 55.37%, with operating and profit margins of 15.80% and 12.30%.

Gross Margin	55.37%
Operating Margin	15.80%
Pretax Margin	18.72%
Profit Margin	12.30%
EBITDA Margin	23.82%
EBIT Margin	15.80%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 20.00, which amounts to a dividend yield of 1.33%.

Dividend Per Share	20.00
Dividend Yield	1.33%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	n/a
Buyback Yield	-0.01%
Shareholder Yield	1.33%
Earnings Yield	2.80%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a